Physician profile
Deirdre Harrington
NPI 1811421944
$842.34
in general payments reported to CMS, 2019-2025
11 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $207 · 2023: $266 · 2024: $82.91 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $456.56 | 2022-2025 | |
| Abbvie INC. | $114.17 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.26 | 2022-2025 | Lifevest |
| Smith+Nephew, INC. | $50.43 | 2023 | Collagenase Santyl |
| Impulse Dynamics (USA) INC. | $28.23 | 2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $27.38 | 2022 | |
| Merck Sharp & Dohme LLC | $26.43 | 2025 | Zerbaxa |
| Medtronic, INC. | $24.48 | 2022 | |
| Alexion Pharmaceuticals, INC. | $24.28 | 2022 | |
| Janssen Pharmaceuticals, INC | $23.34 | 2022 | |
| Abbott Laboratories | $14.78 | 2024 | Jot Dx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deirdre Harrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.